Christina Ackermann - Net Worth and Insider Trading

Christina Ackermann Net Worth

The estimated net worth of Christina Ackermann is at least $3 Million dollars as of 2024-11-13. Christina Ackermann is the Director of Verona Pharma PLC and owns about 41,880 shares of Verona Pharma PLC (VRNA) stock worth over $2 Million. Christina Ackermann is also the EVP AND GENERAL COUNSEL of Bausch Health Companies Inc and owns about 166,758 shares of Bausch Health Companies Inc (BHC) stock worth over $2 Million. Details can be seen in Christina Ackermann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christina Ackermann has not made any transactions after 2024-11-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christina Ackermann

To

Christina Ackermann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christina Ackermann owns 4 companies in total, including CalciMedica Inc (CALC) , Bausch Health Companies Inc (BHC) , and Bausch & Lomb Corp (BLCO) among others .

Click here to see the complete history of Christina Ackermann’s form 4 insider trades.

Insider Ownership Summary of Christina Ackermann

Ticker Comapny Transaction Date Type of Owner
CALC CalciMedica Inc 2020-09-24 director
BHC Bausch Health Companies Inc 2022-02-26 EVP AND GENERAL COUNSEL
BLCO Bausch & Lomb Corp 2022-05-05 Please see remarks
LIMIT LIMIT 2023-09-01 director

Christina Ackermann Latest Holdings Summary

Christina Ackermann currently owns a total of 2 stocks. Among these stocks, Christina Ackermann owns 41,880 shares of Verona Pharma PLC (VRNA) as of November 6, 2024, with a value of $2 Million and a weighting of 51.76%. Christina Ackermann also owns 166,758 shares of Bausch Health Companies Inc (BHC) as of June 2, 2021, with a value of $2 Million and a weighting of 48.24%.

Latest Holdings of Christina Ackermann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRNA Verona Pharma PLC 2024-11-06 41,880 39.00 1,633,320
BHC Bausch Health Companies Inc 2021-06-02 166,758 9.13 1,522,501

Holding Weightings of Christina Ackermann


Christina Ackermann Form 4 Trading Tracker

According to the SEC Form 4 filings, Christina Ackermann has made a total of 1 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Verona Pharma PLC is the acquisition of 41,880 shares on November 6, 2024, which cost Christina Ackermann around $198,511.

According to the SEC Form 4 filings, Christina Ackermann has made a total of 2 transactions in Bausch Health Companies Inc (BHC) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Bausch Health Companies Inc is the sale of 121,198 shares on June 2, 2021, which brought Christina Ackermann around $4 Million.

Insider Trading History of Christina Ackermann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christina Ackermann Trading Performance

GuruFocus tracks the stock performance after each of Christina Ackermann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christina Ackermann is -3%. GuruFocus also compares Christina Ackermann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christina Ackermann within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christina Ackermann's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christina Ackermann

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.76 LIMIT LIMIT LIMIT LIMIT LIMIT

Christina Ackermann Ownership Network

Ownership Network List of Christina Ackermann

No Data

Ownership Network Relation of Christina Ackermann

Insider Network Chart

Christina Ackermann Owned Company Details

What does CalciMedica Inc do?

Who are the key executives at CalciMedica Inc?

Christina Ackermann is the director of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp , and director & 10 percent owner Fred A Middleton .

CalciMedica Inc (CALC) Insider Trades Summary

Over the past 18 months, Christina Ackermann made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 136,737 shares made by Eric W Roberts , a net purchase of 41,768 shares made by A. Rachel Leheny , and a net purchase of 798,842 shares made by Fred A Middleton .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 387,154 shares, with a net purchase of 387,154 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,960,290 shares were bought by its insiders, resulting in a net purchase of 1,960,290 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CalciMedica Inc Insider Transactions

No Available Data

Christina Ackermann Mailing Address

Above is the net worth, insider trading, and ownership report for Christina Ackermann. You might contact Christina Ackermann via mailing address: C/o Blco, 400 Somerset Corporate Blvd., Bridgewater Nj 08807.